Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

(2014) K. M. Schmainda et al.   NEURO-ONCOLOGY

Applications of the Repeatability of Quantitative Imaging Biomarkers: A Review of Statistical Analysis of Repeat Data Sets

(2014) Huiman X. Barnhart et al.   Translational Oncology

Multiparametric Characterization of Grade 2 Glioma Subtypes Using Magnetic Resonance Spectroscopic, Perfusion, and Diffusion Imaging

(2014) Wei Bian et al.   Translational Oncology

Variations of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Evaluation of Breast Cancer Therapy Response: A Multicenter Data Analysis Challenge

(2014) Wei Huang et al.   Translational Oncology

Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study

(2013) J. L. Boxerman et al.   NEURO-ONCOLOGY

Utility of multiparametric 3-T MRI for glioma characterization

(2013) Bhaswati Roy et al.   NEURORADIOLOGY

Low Incidence of Pseudoprogression by Imaging in Newly Diagnosed Glioblastoma Patients Treated With Cediranib in Combination With Chemoradiation

(2013) M. C. Pinho et al.   ONCOLOGIST

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard

(2012) J. L. Boxerman et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Perfusion MRI: The Five Most Frequently Asked Technical Questions

(2012) Marco Essig et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM

(2012) Emma Essock-Burns et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

(2012) J. G. Perez-Larraya et al.   NEURO-ONCOLOGY

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival

(2012) L. S. Hu et al.   NEURO-ONCOLOGY

Accuracy and Reliability Assessment of CT and MR Perfusion Analysis Software Using a Digital Phantom

(2012) Kohsuke Kudo et al.   RADIOLOGY

Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas

(2011) H Thomsen et al.   ACTA RADIOLOGICA

Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma

(2011) L.S. Hu et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

(2011) L.C. Hygino da Cruz et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors

(2011) Taiichi Saito et al.   EUROPEAN JOURNAL OF RADIOLOGY

Treatment Monitoring in Gliomas

(2011) Jonathan Vöglein et al.   INVESTIGATIVE RADIOLOGY

Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas

(2011) Michael A. Vogelbaum et al.   NEUROSURGERY

Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons

(2010) Devyani Bedekar et al.   MAGNETIC RESONANCE IN MEDICINE

Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading

(2010) Andrés Server et al.   NEURORADIOLOGY

Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma

(2010) Rajiv Mangla et al.   RADIOLOGY

Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas

(2009) L.S. Hu et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting

(2009) Gisele B. Caseiras et al.   EUROPEAN JOURNAL OF RADIOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements

(2008) L.S. Hu et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

The role of clinical imaging in oncological drug development

(2008) P S MURPHY et al.   BRITISH JOURNAL OF RADIOLOGY

Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors

(2008) Eric S. Paulson et al.   RADIOLOGY